BICYCLE THERAPEUTICS (BCYC) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$3.89
+2.1% on the day
-56.1% over 12 months
52-week range $3.38 – $8.87
Share price and insider trades
BCYC closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$523K
Insiders buying0
Insiders selling8
BICYCLE THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $523K of BCYC stock on the open market.
Get emailed when insiders cluster-buy stocks like BCYC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BCYC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $64K | 14 |
| Q3 2026 | — | 0 | $60K | 11 |
| Q2 2026 | — | 0 | $70K | 11 |
| Q1 2026 | — | 0 | $328K | 13 |
| Q4 2025 | — | 0 | $93K | 13 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 BICYCLE THERAPEUTICS PLC insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $523K. 17 of 62 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 7SEC | Jennifer Scott PerryCOO | Sell Plan | 32689,602 held (−0%) | $3.78 | $1K | +2.9% | — |
| Oct 7SEC | Jennifer Scott PerryCOO | Sell Plan | 3089,928 held (−0%) | $3.57 | $107 | +9.0% | — |
| Oct 6SEC | Kevin LeeCEO | Sell | 6,167597,504 held (−1%) | $3.47 | $21K | +12.1% | — |
| Oct 6SEC | Robert Charles SwantonDirector | Sell | 3,43115,782 held (−18%) | $3.47 | $12K | +12.1% | — |
| Oct 6SEC | Michael SkynnerChief Scientific Officer | Sell | 1,942155,229 held (−1%) | $3.47 | $7K | +12.1% | — |
| Oct 6SEC | Kevin LeeCEO | Sell | 1,638595,866 held (−0%) | $3.57 | $6K | +9.0% | — |
| Oct 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 1,57292,803 held (−2%) | $3.47 | $5K | +12.1% | — |
| Oct 6SEC | Jennifer Scott PerryCOO | Sell Plan | 1,09489,958 held (−1%) | $3.47 | $4K | +12.1% | — |
| Oct 6SEC | Travis Alvin ThompsonCFO | Sell | 89364,528 held (−1%) | $3.47 | $3K | +12.1% | — |
| Oct 6SEC | Michael SkynnerChief Scientific Officer | Sell | 503154,726 held (−0%) | $3.57 | $2K | +9.0% | — |
| Oct 6SEC | Jennifer Scott PerryCOO | Sell Plan | 32689,552 held (−0%) | $3.78 | $1K | +2.9% | — |
| Oct 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 24292,561 held (−0%) | $3.57 | $864 | +9.0% | — |
| Oct 6SEC | Jennifer Scott PerryCOO | Sell Plan | 8089,878 held (−0%) | $3.56 | $285 | +9.3% | — |
| Oct 6SEC | Travis Alvin ThompsonCFO | Sell | 7964,449 held (−0%) | $3.57 | $282 | +9.0% | — |
| Jul 7SEC | Kevin LeeCEO | Sell | 5,905605,408 held (−1%) | $4.27 | $25K | -8.9% | — |
| Jul 7SEC | Michael SkynnerChief Scientific Officer | Sell | 1,859157,703 held (−1%) | $4.27 | $8K | -8.9% | — |
| Jul 7SEC | Kevin LeeCEO | Sell | 1,737603,671 held (−0%) | $4.31 | $7K | -9.7% | — |
| Jul 7SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 1,50694,630 held (−2%) | $4.27 | $6K | -8.9% | — |
| Jul 7SEC | Jennifer Scott PerryCOO | Sell Plan | 1,03691,428 held (−1%) | $4.27 | $4K | -8.9% | — |
| Jul 7SEC | Travis Alvin ThompsonCFO | Sell | 81964,545 held (−1%) | $4.27 | $3K | -8.9% | — |
| Jul 7SEC | Michael SkynnerChief Scientific Officer | Sell | 532157,171 held (−0%) | $4.31 | $2K | -9.7% | — |
| Jul 7SEC | Jennifer Scott PerryCOO | Sell Plan | 33391,052 held (−0%) | $4.34 | $1K | -10.4% | — |
| Jul 7SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 25594,375 held (−0%) | $4.31 | $1K | -9.7% | — |
| Jul 7SEC | Travis Alvin ThompsonCFO | Sell | 10464,441 held (−0%) | $4.31 | $448 | -9.7% | — |
| Jul 7SEC | Jennifer Scott PerryCOO | Sell Plan | 4391,385 held (−0%) | $4.31 | $185 | -9.7% | — |
| Apr 6SEC | Kevin LeeCEO | Sell | 5,967613,029 held (−1%) | $4.91 | $29K | -20.8% | — |
| Apr 6SEC | Michael SkynnerChief Scientific Officer | Sell | 1,879160,087 held (−1%) | $4.91 | $9K | -20.8% | — |
| Apr 6SEC | Kevin LeeCEO | Sell | 1,716611,313 held (−0%) | $5.05 | $9K | -23.0% | — |
| Apr 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 1,52196,387 held (−2%) | $4.91 | $7K | -20.8% | — |
| Apr 6SEC | Jennifer Scott PerryCOO | Sell Plan | 1,03892,834 held (−1%) | $4.91 | $5K | -20.8% | — |
| Apr 6SEC | Travis Alvin ThompsonCFO | Sell | 79965,466 held (−1%) | $4.91 | $4K | -20.8% | — |
| Apr 6SEC | Michael SkynnerChief Scientific Officer | Sell | 525159,562 held (−0%) | $5.05 | $3K | -23.0% | — |
| Apr 6SEC | Jennifer Scott PerryCOO | Sell Plan | 33392,464 held (−0%) | $5.04 | $2K | -22.8% | — |
| Apr 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 25196,136 held (−0%) | $5.05 | $1K | -23.0% | — |
| Apr 6SEC | Travis Alvin ThompsonCFO | Sell | 10265,364 held (−0%) | $5.05 | $515 | -23.0% | — |
| Apr 6SEC | Jennifer Scott PerryCOO | Sell Plan | 3792,797 held (−0%) | $5.05 | $187 | -23.0% | — |
| Jan 6SEC | Kevin LeeCEO | Sell | 10,989618,996 held (−2%) | $6.46 | $71K | -39.8% | — |
| Jan 6SEC | Kevin LeeCEO | Sell | 10,325629,985 held (−2%) | $6.80 | $70K | -42.8% | — |
| Jan 6SEC | Alethia YoungCFO | Sell Plan | 3,28991,415 held (−3%) | $6.80 | $22K | -42.8% | — |
| Jan 6SEC | Alistair MilnesCOO | Sell | 3,416136,717 held (−2%) | $6.46 | $22K | -39.8% | — |
| Jan 6SEC | Alistair MilnesCOO | Sell | 3,244140,133 held (−2%) | $6.80 | $22K | -42.8% | — |
| Jan 6SEC | Michael SkynnerCTO | Sell | 3,266161,966 held (−2%) | $6.46 | $21K | -39.8% | — |
| Jan 6SEC | Michael SkynnerCTO | Sell | 3,045165,232 held (−2%) | $6.80 | $21K | -42.8% | — |
| Jan 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 2,827100,275 held (−3%) | $6.80 | $19K | -42.8% | — |
| Jan 6SEC | Alethia YoungCFO | Sell Plan | 2,45688,959 held (−3%) | $6.45 | $16K | -39.7% | — |
| Jan 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 2,36797,908 held (−2%) | $6.45 | $15K | -39.7% | — |
| Jan 6SEC | Alethia YoungCFO | Sell Plan | 1,87887,081 held (−2%) | $6.54 | $12K | -40.5% | — |
| Jan 6SEC | Travis Alvin ThompsonChief Accounting Officer | Sell | 1,31767,380 held (−2%) | $6.80 | $9K | -42.8% | — |
| Jan 6SEC | Travis Alvin ThompsonChief Accounting Officer | Sell | 1,11566,265 held (−2%) | $6.45 | $7K | -39.7% | — |
| Oct 6SEC | Kevin LeeCEO | Sell | 3,231475,310 held (−1%) | $8.41 | $27K | -53.7% | — |
| Oct 6SEC | Kevin LeeCEO | Sell | 2,263478,541 held (−0%) | $8.40 | $19K | -53.7% | — |
| Oct 6SEC | Alistair MilnesCOO | Sell | 1,14794,355 held (−1%) | $8.40 | $10K | -53.7% | — |
| Oct 6SEC | Michael SkynnerCTO | Sell | 978118,277 held (−1%) | $8.41 | $8K | -53.7% | — |
| Oct 6SEC | Alistair MilnesCOO | Sell | 97893,377 held (−1%) | $8.41 | $8K | -53.7% | — |
| Oct 6SEC | Michael SkynnerCTO | Sell | 824119,255 held (−1%) | $8.40 | $7K | -53.7% | — |
| Oct 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 47353,352 held (−1%) | $8.40 | $4K | -53.7% | — |
| Oct 6SEC | Alethia YoungCFO | Sell Plan | 26544,704 held (−1%) | $8.61 | $2K | -54.8% | — |
| Oct 6SEC | Michael Charles Ferguson HannayChief Prod & Supply Chain Off | Sell | 25053,102 held (−0%) | $8.41 | $2K | -53.7% | — |
| Oct 6SEC | Travis Alvin ThompsonChief Accounting Officer | Sell | 22131,300 held (−1%) | $8.40 | $2K | -53.7% | — |
| Oct 6SEC | Alethia YoungCFO | Sell Plan | 21744,969 held (−0%) | $8.40 | $2K | -53.7% | — |
| Oct 6SEC | Robert Charles SwantonDirector | Sell Plan | 10215,487 held (−1%) | $8.55 | $872 | -54.5% | — |
| Oct 6SEC | Travis Alvin ThompsonChief Accounting Officer | Sell | 10331,197 held (−0%) | $8.41 | $866 | -53.7% | — |
Insiders at BICYCLE THERAPEUTICS PLC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Kevin LeeCEO | — | $285K | Oct 6, 2026 | — |
| Michael SkynnerChief Scientific Officer | — | $88K | Oct 6, 2026 | — |
| Michael Charles Ferguson HannayChief Prod & Supply Chain Off | — | $63K | Oct 6, 2026 | — |
| Alistair MilnesCOO | — | $62K | Jan 6, 2026 | — |
| Alethia YoungCFO | — | $55K | Jan 6, 2026 | — |
| Travis Alvin ThompsonCFO | — | $31K | Oct 6, 2026 | — |
| Jennifer Scott PerryCOO | — | $20K | Oct 7, 2026 | — |
| Robert Charles SwantonDirector | — | $13K | Oct 6, 2026 | — |
BCYC stock: common questions
Are BICYCLE THERAPEUTICS PLC insiders buying BCYC stock?
In the past 12 months, 0 insiders reported open-market purchases of BCYC worth $0.
Are BICYCLE THERAPEUTICS PLC insiders selling BCYC stock?
8 insiders reported sales worth $523K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BCYC's 52-week range?
Over the past year BCYC has traded between $3.38 and $8.87. It last closed at $3.89 on Oct 9, 2026.